While it was first identified in oesophageal squamous cell carcinoma30, GRIN2B has been subsequently confirmed in many other cancer types, such as oesophageal cancer, gastric cancer and breast cancer31–33. Here, GRIN2B is linked to carcinoma of esophagus.